Patient tagging device for reducing medical errors gets US nod
This article was originally published in Clinica
The FDA has cleared for sale in the US a noninvasive tagging system aimed at safeguarding against surgical mishaps. The skin-mounted adhesive, called SurgiChip, is expected to remove the risk of patients being given the wrong surgical procedure or treated at the wrong site of injury. The product's Palm Beach Gardens, Florida based developer, also known as SurgiChip, says the product is the first external surgical marker to implement radiofrequency identification (RFID) technology.
You may also be interested in...
Following the US request for ranitidine drugs to be withdrawn from the market, the European Medicines Agency says it would decide the fate of the products in the EU after wrapping up its own inquiry.
Perrigo will launch generics of GSK's OTC Voltaren Arthritis Pain drug later in 2020 following FDA approval of its ANDA. GSK, which received FDA's OTC switch approval in February, still hasn't launched the product or indicated when it will.
Kline & Company’s worst-case scenario – which it says is looking more and more likely – has the US cosmetics and personal-care market declining by as much as 8.1% in 2020. However, Kline, Mintel and other market intelligence firms say there are opportunities available to companies struggling to weather the COVID-19 storm.